{{Rsnum
|rsid=1078985
|Gene=TGFBR2
|Chromosome=3
|position=30649419
|Orientation=minus
|GMAF=0.2305
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TGFBR2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.6 | 45.1 | 44.2
| HCB | 2.2 | 22.6 | 75.2
| JPT | 4.4 | 35.4 | 60.2
| YRI | 4.8 | 37.4 | 57.8
| ASW | 1.8 | 33.3 | 64.9
| CHB | 2.2 | 22.6 | 75.2
| CHD | 1.8 | 22.0 | 76.1
| GIH | 11.9 | 35.6 | 52.5
| LWK | 0.9 | 26.4 | 72.7
| MEX | 1.7 | 25.9 | 72.4
| MKK | 9.0 | 28.8 | 62.2
| TSI | 4.9 | 52.0 | 43.1
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19434696
|Title=Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm
}}

A 2009 report concludes that SNPs in the [[TGFBR2]] gene do not appear to affect risk of [[abdominal aortic aneurysm]] (AAA). {{PMID|19434696}}

{{PharmGKB
|RSID=rs1078985
|Name_s=rs1078985 T/C TGFBR2
|Gene_s=TGFBR2
|Feature=
|Evidence=PubMed ID:20157331
|Annotation=Risk or phenotype-associated allele: Not specified. Phenotype: This SNP was associated with clearance of docetaxel. Study size: 31. Study population/ethnicity: Patients with Non-Small-Cell Lung Carcinoma. Significance metric(s): p = 0.0355 (ANOVA); p = 0.1156 (QMIS); p = 0.0830 (KW) Type of association: PK.
|Drugs=docetaxel
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA165291797
}}

{{PMID Auto
|PMID=22539603
|Title=Pathway Analyses Identify TGFBR2 as Potential Breast Cancer Susceptibility Gene: Results from a Consortium Study among Asians.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1078985
|overall_frequency_n=27
|overall_frequency_d=128
|overall_frequency=0.210938
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}